Related Experiment Videos
Dynamic pathology of the heart, a personal odyssey
1Department of Pathology, New York University School of Medicine, Orangeburg.
Insights
Cardiovascular pathology has advanced from autopsy data to molecular insights. New techniques allow dynamic study of heart disease, moving beyond static histologic interpretations for better therapies.
Area of Science:
- Cardiovascular Pathology
- Molecular Cardiology
- Cardiac Physiology
Background:
- Historically, cardiovascular pathology relied on autopsy data.
- Advancements in molecular biology, biochemistry, and physiology have transformed understanding of heart health and disease.
- Professor FZ Meerson's early work characterized biochemical events in myocardial degeneration.
Purpose of the Study:
- To highlight the shift from static histologic interpretations to dynamic molecular and cellular insights in cardiovascular pathology.
- To emphasize the realization of Professor Meerson's prophetic insights regarding cardiac muscle cell research.
- To underscore the evolving role of pathologists in understanding dynamic heart disease.
Main Methods:
- Leveraging new knowledge in molecular biology, biochemistry, physiology, and pharmacology.
- Utilizing techniques for identifying and localizing key chemical entities within cardiac muscle cells.
- Integrating findings from Professor Meerson's pioneering animal studies on acute aortic constriction.
Main Results:
- Pioneering work by Meerson elucidated biochemical events leading to myocardial degeneration and cell death.
- Modern techniques now allow for the identification and localization of key chemical entities in cardiac cells, correlating with function.
- This has led to a rapid understanding of pathogenesis and the development of new therapies.
Conclusions:
- The study of cardiovascular pathology has transitioned to a dynamic, science-based approach.
- Molecular and cellular insights have revolutionized the understanding of heart disease pathogenesis.
- Pathologists are now equipped to lead the way in studying the dynamic pathology of the heart.
Abstract:
As a student of cardiovascular pathology in humans and animals for 35 yr, I am impressed with the new knowledge of the molecular biology, biochemistry, physiology and pharmacology of the heart in health and disease. All of this information creates a dynamic setting for the interpretation of structural findings. Before the advent of open-heart surgery and the cardiac biopsy, pathologists had to rely largely on accumulated autopsy data. Today, a great deal of empiric dogma has given way to good science. In 1962, I met Professor FZ Meerson in his laboratory in the Institute of Normal and Abnormal Physiology, Moscow. He had just characterized the biochemical events leading to myocardial degeneration and cell death in animals with acute aortic constriction (19). His pioneering work provided the basis for understanding the sequential changes in myocytes in the failing heart. These cellular events corresponded to the astute clinical observations made by Osler in 1886. Meerson was enthusiastic about the potential of electron microscopy. However, he was convinced that when we had the techniques to identify and localize in the cardiac muscle cell the key chemical entities associated with changing function, we would rapidly understand pathogenesis leading to new therapies. Today, almost 30 yr later, Meerson's prophetic insights have become a reality. I had assured Meerson that when the tools were available to study the dynamic pathology of the heart, pathologists would lead the way. Dynamic pathology of the heart is a concept since the words are somewhat contradictory. The term serves as a symbol for a state of mind which refuses to interpret cardiovascular pathology in static, histologic words.(ABSTRACT TRUNCATED AT 250 WORDS)